Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
1611 Preoperative gemcitabine based chemo-radiotherapy in locally advanced non metastatic pancreatic adenocarcinoma Department of Surgical Oncology Prof. Doaa Wadie Maximous Dawoud 2009
1612 Effect of Bevacizumab, a Humanized Monoclonal Antibody to Vascular
Endothelial Growth Factor, on Peritoneal Metastasis of MNK-45P
Human Gastric Cancer in Mice 		Department of Surgical Oncology Dr. Anwar Tawfik Amin 2009
1613 Immunophenotyping and immunoglobulin heavy chain gene rearrangement analysis in cerebrospinal fluid of pediatric patients with acute lymphoblastic leukemia.
 		Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2009
1614 Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study Department of Pediatric Oncology Dr. Nasreen Mohamed Ali Khalifa 2008
1615 Diagnostic performance and predictive value of rheumatoid factor anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2008
1616 Fetus in fetu: a case report Department of Pediatric Oncology Dr. Nasreen Mohamed Ali Khalifa 2008
1617 Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2008
1618 Pharmacokinetics of oral tramadol in patients with liver cancer.
 		Department of Anesthesia, Intensive care and Pain management Prof. Mustafa Galal Mustafa Hassan 2008
1619 Diagnostic performance and predictive value of rheumatoid factor anti-cyclic-citrullinated peptide antibodies and HLA-DRB1 locus genes in rheumatoid arthritis Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2008
1620 Persistence of TEL-AML1 fusion gene as minimal residual disease has no additive prognostic value in CD 10 positive B-acute lymphoblastic leukemia: a FISH study.
 		Department of Clinical Pathology Prof. Eman Massad Zaki El-Hefny 2008